Terfluranol
Jump to navigation
Jump to search
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H17F3O2 |
Molar mass | 310.316 g·mol−1 |
3D model (JSmol) | |
| |
|
Terfluranol (INN, BAN) (developmental code name BX-428) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of breast cancer but was never marketed.[1][2] It was described in the medical literature in 1974.[1]
See also
References
- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 1161. ISBN 978-1-4757-2085-3.
- ^ Polska Akademia Nauk. Komitet Badania Polonii (1984). II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów. Zakład Narodowy im. Ossolińskich. p. 451. ISBN 978-83-04-01670-5.
Categories:
- Articles with short description
- Short description is different from Wikidata
- Drugs not assigned an ATC code
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Organofluorides
- Phenols
- Synthetic estrogens
- Trifluoromethyl compounds
- All stub articles
- Genito-urinary system drug stubs